AP2012006390A0 - Tricyclic pyridine derivatives, medicaments containing such compounds, their use and process for their preparation - Google Patents

Tricyclic pyridine derivatives, medicaments containing such compounds, their use and process for their preparation

Info

Publication number
AP2012006390A0
AP2012006390A0 AP2012006390A AP2012006390A AP2012006390A0 AP 2012006390 A0 AP2012006390 A0 AP 2012006390A0 AP 2012006390 A AP2012006390 A AP 2012006390A AP 2012006390 A AP2012006390 A AP 2012006390A AP 2012006390 A0 AP2012006390 A0 AP 2012006390A0
Authority
AP
ARIPO
Prior art keywords
compounds
preparation
pyridine derivatives
medicaments containing
tricyclic pyridine
Prior art date
Application number
AP2012006390A
Other languages
English (en)
Inventor
Ingo Konetzki
Riccardo Giovannini
Holger Wagner
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of AP2012006390A0 publication Critical patent/AP2012006390A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4741—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having oxygen as a ring hetero atom, e.g. tubocuraran derivatives, noscapine, bicuculline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/20—Spiro-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AP2012006390A 2010-02-19 2011-02-17 Tricyclic pyridine derivatives, medicaments containing such compounds, their use and process for their preparation AP2012006390A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP10154086 2010-02-19
PCT/EP2011/052376 WO2011101424A1 (en) 2010-02-19 2011-02-17 Tricyclic pyridine derivatives, medicaments containing such compounds, their use and process for their preparation

Publications (1)

Publication Number Publication Date
AP2012006390A0 true AP2012006390A0 (en) 2012-08-31

Family

ID=43877277

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2012006390A AP2012006390A0 (en) 2010-02-19 2011-02-17 Tricyclic pyridine derivatives, medicaments containing such compounds, their use and process for their preparation

Country Status (23)

Country Link
US (2) US9029544B2 (de)
EP (1) EP2536733B1 (de)
JP (1) JP5780528B2 (de)
KR (1) KR20130000379A (de)
CN (1) CN102869667A (de)
AP (1) AP2012006390A0 (de)
AR (1) AR080228A1 (de)
AU (1) AU2011217206A1 (de)
BR (1) BR112012020591A2 (de)
CA (1) CA2790643A1 (de)
CL (1) CL2012002035A1 (de)
CO (1) CO6592112A2 (de)
EA (1) EA201201160A1 (de)
EC (1) ECSP12012157A (de)
MA (1) MA34007B1 (de)
MX (1) MX2012009149A (de)
PE (1) PE20121743A1 (de)
PH (1) PH12012501661A1 (de)
SG (1) SG183321A1 (de)
TN (1) TN2012000418A1 (de)
TW (1) TW201139445A (de)
UY (1) UY33229A (de)
WO (1) WO2011101424A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0909105A2 (pt) * 2008-03-05 2015-08-25 Boehringer Ingelheim Int Derivados de piridina tricíclicos, composição farmacêutica e uso dos mesmos, bem como processos para preparar os ditos compostos e a dita composição farmacêutica
UY33229A (es) 2010-02-19 2011-09-30 Boehringer Ingelheim Int Derivados de piridina tricíclicos, medicamentos que contienen tales compuestos, su uso y proceso pa ra su preparación
EP2675811A1 (de) * 2011-02-17 2013-12-25 Boehringer Ingelheim International GmbH Tricyclische pyridinderivate, medikamente mit solchen verbindungen, ihre verwendung und herstellungsverfahren dafür
EP2760868B1 (de) * 2011-08-17 2018-04-25 Boehringer Ingelheim International GmbH Furo[3,4-c]chinolinderivate, medikamente mit solchen verbindungen, ihre verwendung und herstellungsverfahren dafür
US20130210851A1 (en) * 2011-08-18 2013-08-15 Boehringer Ingelheim International Gmbh Crystalline forms of a hexahydrofuro[3,4-c]quinoline derivative
US8633182B2 (en) 2012-05-30 2014-01-21 Boehringer Ingelheim International Gmbh Indanyloxyphenylcyclopropanecarboxylic acids
CN103882766B (zh) * 2014-03-21 2015-10-28 湖南中烟工业有限责任公司 一种除去包装卡纸中酮类物质的除酮添加剂及其应用
CN103866646B (zh) * 2014-03-21 2015-10-28 湖南中烟工业有限责任公司 一种生产无酮转移卡纸的工艺

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4798619A (en) 1980-06-02 1989-01-17 American Cyanamid Co. 2-(2-imidazolin-2-yl)-pyridines and quinolines and use of said compounds as herbicidal agents
US4475407A (en) 1982-12-27 1984-10-09 Brunswick Corporation Temperature compensated flow sensor
CH664578A5 (de) * 1985-01-15 1988-03-15 Ciba Geigy Ag Ringsubstituierte 4-azaphthalide.
JPH04500506A (ja) 1988-08-16 1992-01-30 ジ・アップジョン・カンパニー Ａｃａｔ酵素をブロックするのに有効な二価リガンド類
PL186781B1 (pl) 1995-09-29 2004-02-27 Glaxo Wellcome Spa Nowy związek, pochodna tetrahydrochinoliny, sposób wytwarzania pochodnej tetrahydrochinoliny, środek farmaceutyczny i zastosowanie
HRP970330B1 (en) * 1996-07-08 2004-06-30 Bayer Ag Cycloalkano pyridines
DE19627431A1 (de) 1996-07-08 1998-01-15 Bayer Ag Heterocyclisch kondensierte Pyridine
JP2894445B2 (ja) 1997-02-12 1999-05-24 日本たばこ産業株式会社 Ｃｅｔｐ活性阻害剤として有効な化合物
KR20010023615A (ko) 1997-09-04 2001-03-26 스타르크, 카르크 신규 카르복실산 유도체, 그 제조 및 혼합 ｅｔａ/ｅｔｂ엔도텔린 수용체 길항제로서의 용도
DE19741051A1 (de) 1997-09-18 1999-03-25 Bayer Ag Hetero-Tetrahydrochinoline
US6197786B1 (en) 1998-09-17 2001-03-06 Pfizer Inc 4-Carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines
JP3924124B2 (ja) 1998-09-25 2007-06-06 ファルマシア・コーポレーション コレステロールエステル輸送タンパク質活性阻害に有効な置換された多環アリールおよびヘテロアリール第三級ヘテロアルキルアミン
US20010018446A1 (en) 1999-09-23 2001-08-30 G.D. Searle & Co. Substituted N-Aliphatic-N-Aromatictertiary-Heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
US6479552B2 (en) 1999-09-23 2002-11-12 G.D. Searle & Co. Use of substituted N, N-disubstituted diamino compounds for inhibiting cholesteryl ester transfer protein activity
US6683113B2 (en) 1999-09-23 2004-01-27 Pharmacia Corporation (R)-chiral halogenated substituted N,N-Bis-benzyl aminioalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
DE10148436A1 (de) * 2001-10-01 2003-04-17 Bayer Ag Tetrahydrochinoline
DE10238243A1 (de) * 2002-08-21 2004-03-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg 8-[3-Amino-piperidin-1-yl]-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
CA2562082C (en) 2004-04-13 2013-06-25 Merck & Co., Inc. Cetp inhibitors for the treatment and prevention of atherosclerosis
PE20060653A1 (es) 2004-08-31 2006-09-27 Glaxo Group Ltd Derivados triciclicos condensados como moduladores del receptor 5-ht1
ES2384980T3 (es) 2004-12-18 2012-07-16 Bayer Pharma Aktiengesellschaft Derivados de tetrahidroquinolina sustituidos en 4 con cicloalquilo y su uso como medicamentos
DE102004060997A1 (de) * 2004-12-18 2006-06-22 Bayer Healthcare Ag Chemische Verbindung und ihre Verwendung
BRPI0519566A2 (pt) 2004-12-18 2009-01-27 Bayer Healthcare Ag derivados de (5s)-3-[(s)-fléor(4-trifluormetilfenil)metil]-5,6,7,8-tet raidroquinolin-5-ol e seu uso como inibidores de cetp
JP2008201760A (ja) 2007-02-22 2008-09-04 Tokyo Univ Of Agriculture & Technology 光学活性スピロ化合物及びその製造方法
BRPI0909105A2 (pt) 2008-03-05 2015-08-25 Boehringer Ingelheim Int Derivados de piridina tricíclicos, composição farmacêutica e uso dos mesmos, bem como processos para preparar os ditos compostos e a dita composição farmacêutica
TWI396689B (zh) 2008-11-14 2013-05-21 Amgen Inc 作為磷酸二酯酶１０抑制劑之吡衍生物
UY33229A (es) 2010-02-19 2011-09-30 Boehringer Ingelheim Int Derivados de piridina tricíclicos, medicamentos que contienen tales compuestos, su uso y proceso pa ra su preparación
EP2675811A1 (de) * 2011-02-17 2013-12-25 Boehringer Ingelheim International GmbH Tricyclische pyridinderivate, medikamente mit solchen verbindungen, ihre verwendung und herstellungsverfahren dafür
EP2760868B1 (de) 2011-08-17 2018-04-25 Boehringer Ingelheim International GmbH Furo[3,4-c]chinolinderivate, medikamente mit solchen verbindungen, ihre verwendung und herstellungsverfahren dafür
US20130210851A1 (en) 2011-08-18 2013-08-15 Boehringer Ingelheim International Gmbh Crystalline forms of a hexahydrofuro[3,4-c]quinoline derivative

Also Published As

Publication number Publication date
EP2536733A1 (de) 2012-12-26
JP2013519709A (ja) 2013-05-30
US20120046304A1 (en) 2012-02-23
BR112012020591A2 (pt) 2017-10-10
EP2536733B1 (de) 2014-11-26
CN102869667A (zh) 2013-01-09
MA34007B1 (fr) 2013-02-01
SG183321A1 (en) 2012-09-27
MX2012009149A (es) 2012-09-28
WO2011101424A1 (en) 2011-08-25
TW201139445A (en) 2011-11-16
TN2012000418A1 (en) 2014-01-30
US20120053197A1 (en) 2012-03-01
CL2012002035A1 (es) 2013-02-01
CO6592112A2 (es) 2013-01-02
KR20130000379A (ko) 2013-01-02
JP5780528B2 (ja) 2015-09-16
CA2790643A1 (en) 2011-08-25
PH12012501661A1 (en) 2012-10-22
EA201201160A1 (ru) 2013-04-30
ECSP12012157A (es) 2012-10-30
AU2011217206A1 (en) 2012-08-02
AR080228A1 (es) 2012-03-21
UY33229A (es) 2011-09-30
US9029544B2 (en) 2015-05-12
PE20121743A1 (es) 2012-12-22

Similar Documents

Publication Publication Date Title
IL231382A (en) History of benzonitrile, their preparation and medications containing them
IL231009A (en) The heterotromatic compounds in the oak, their preparation and their pharmaceutical preparations
ZA201209632B (en) Imidazopyridine derivatives, process for the preparation thereof and therapeutic use thereof
IL237073A (en) History of pyridopyrimidine, their preparation and their pharmaceutical preparations
IL229863A0 (en) The history of pyrimidine and pyridine, their preparation and pharmaceutical preparations containing them
IL230218A (en) Converted atherothecyclic compounds, their preparations and their pharmaceutical preparations
IL237839A0 (en) History of hydropyrrolopyrrole, their preparation and pharmaceutical preparations containing them
IL235414A (en) The history of pyrolotriazinone, their preparation and their pharmaceutical preparations
AP2014007670A0 (en) Heterocyclic compounds, medicaments containing said compounds, use thereof and processes for the preparation thereof
IL238060B (en) 2-aminopyridine derivatives, their preparation and pharmaceutical compositions containing them
IL226094A0 (en) The history of pyrazine, their preparation and pharmaceutical preparations containing them
AP2012006390A0 (en) Tricyclic pyridine derivatives, medicaments containing such compounds, their use and process for their preparation
IL232577A (en) History of morpholinylbenzotriazine, their preparation and their pharmaceutical preparations
IL223872A (en) Pyrazoloquinoline derivatives and intermediates, process for preparation, use and pharmaceutical preparations and preparations containing them
IL207183A (en) Dihydroindolone compounds, a process for their preparation and their pharmaceutical compositions
IL207263A0 (en) Tricyclic pyridine derivatives, medicaments containing such compounds, their use and process for their preparation
IL227404A0 (en) Pyrimidine history, their preparation and pharmaceutical preparations containing them
IL230219A0 (en) History of dihydropyrazole, their preparation and pharmaceutical preparations containing them
IL225105A (en) Heterocyclic compounds, their process, their pharmaceutical preparations and their use in the preparation of drugs
IL230834A0 (en) History of pyrido-pyrimidine, their preparation and medicines containing them
ZA201305227B (en) Pharmaceutical composition comprising pyridone derivatives
IL225823A0 (en) History of quinazoline, their preparation and pharmaceutical preparations containing them
IL238826A0 (en) History of imidazole - piperidinyl, their preparation and pharmaceutical preparations containing them
HUP1100532A2 (en) Substituted curcumin derivatives, process for their preparation, and pharmaceutical compositions containing them
SI2497774T1 (sl) Derivati dihidrooksazolobenzodiazepinona, postopki za njihovo pripravo in farmacevtski sestavki, ki te spojine vsebujejo